Among patients with coronavirus disease (COVID-19), IgM levels increased early after symptom onset for those with mild and severe disease, but IgG levels increased early only in those with severe disease. A similar pattern was observed in a separate serosurveillance cohort. Mild COVID-19 should be investigated separately from severe COVID-19.
All Keywords
【저자키워드】 COVID-19, 2019 novel coronavirus disease, coronavirus disease, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, zoonoses, SARS-CoV-2, neutralization, Georgia, Immunoglobulin, infection severity, USA, antibody profiles, Atlanta, 【초록키워드】 IgM, severe COVID-19, Cohort, Patient, Mild, severe disease, symptom onset, investigated, IgG level, 【제목키워드】 profile,
【저자키워드】 COVID-19, 2019 novel coronavirus disease, coronavirus disease, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, zoonoses, SARS-CoV-2, neutralization, Georgia, Immunoglobulin, infection severity, USA, antibody profiles, Atlanta, 【초록키워드】 IgM, severe COVID-19, Cohort, Patient, Mild, severe disease, symptom onset, investigated, IgG level, 【제목키워드】 profile,
코로나바이러스감염증-19(COVID-19) 환자 중 경증·중증 환자는 증상 발현 후 IgM 수치가 일찍 증가했지만, 중증 환자에서만 조기에 IgG 수치가 증가했다. 별도의 혈청 감시 코호트에서도 유사한 패턴이 관찰되었습니다. 경증 COVID-19는 중증 COVID-19와 별도로 조사해야 합니다.